Sugarman-Brozan says FDA is neglecting enforcement

Share this article:
Prescription Access Litigation project director Alex Sugarman-Brozan told the Third Annual FDA Regulatory Symposium at Harvard in August that the agency is neglecting to enforce regulations on DTC advertising and needs to crack down on drug companies with more and earlier enforcement letters and hefty fines on offending companies, per pending regs.

Share this article:
close

Next Article in Features

Email Newsletters

More in Features

Read the complete April 2014 Digital Edition

Read the complete April 2014 Digital Edition

Click the above link to access the complete Digital Edition of the April 2014 issue of MM&M, with all text, charts and pictures.

Antidote: Are e-cigarettes safe?

Antidote: Are e-cigarettes safe?

The pros and cons of e-cigarettes

Combating concept churn

Combating concept churn

There's no cure. But the good news is that prophylaxis is possible.